tumor protein p53 ; Homo sapiens






17006 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 1279184 Mutations of p53 gene in hepatocellular carcinoma: roles of hepatitis B virus and aflatoxin contamination in the diet. J Natl Cancer Inst 1992 Nov 4 4
2 1279244 High incidence of nuclear accumulation of p53 protein in gastric cancer. Jpn J Clin Oncol 1992 Aug 3
3 1280773 Altered structure and expression of the p53 gene in human neuroepithelial tumors. Neurol Med Chir (Tokyo) 1992 Sep 2
4 1295480 Immunohistochemical detection of mutant p53-suppressor gene product in patients with breast cancer: influence on metastasis-free survival. Anticancer Res 1992 Nov-Dec 1
5 1303002 [The role of p53 gene in the switch of U937 leukemic cells from growth into differentiation]. Shi Yan Sheng Wu Xue Bao 1992 Dec 3
6 1310637 Low frequency of p53 gene mutation in tumors induced by aflatoxin B1 in nonhuman primates. Cancer Res 1992 Feb 15 4
7 1317462 Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. J Natl Cancer Inst 1992 Jun 3 2
8 1319835 Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenomatous polyposis patients. Cancer Res 1992 Jul 15 2
9 1322785 p53 gene mutations in human gastric cancer: wild-type p53 but not mutant p53 suppresses growth of human gastric cancer cells. Cancer Res 1992 Aug 15 2
10 1322917 Elevation of large-T antigen production by sodium butyrate treatment of SV40-transformed WI-38 fibroblasts. J Cell Biochem 1992 May 5
11 1324739 Cell and molecular biology of gastrointestinal tract cancer. Curr Opin Oncol 1992 Aug 1
12 1324804 Autocrine motility factor and its receptor: role in cell locomotion and metastasis. Cancer Metastasis Rev 1992 Mar 1
13 1330291 p53 gene mutation spectrum in hepatocellular carcinoma. Cancer Res 1992 Nov 15 1
14 1330867 Overexpression of p53: a rare event in a large series of white patients with hepatocellular carcinoma. Hepatology 1992 Nov 1
15 1332185 Tumours of the liver. Scand J Gastroenterol Suppl 1992 5
16 1332921 Analysis of the p53 tumor-suppressor gene in hepatocellular carcinomas from Britain. Hepatology 1992 Dec 1
17 1347094 Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners. Lancet 1992 Mar 7 2
18 1347900 p53 codon 249ser mutations in hepatocellular carcinoma patients with low aflatoxin exposure. Lancet 1992 Apr 4 1
19 1352359 Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients. J Natl Cancer Inst 1992 Jul 15 1
20 1358781 Expression of p53 in human esophageal carcinoma: an immunohistochemical study with correlation to proliferating cell nuclear antigen expression. Hum Pathol 1992 Nov 3
21 1370482 Okadaic acid mimics multiple changes in early protein phosphorylation and gene expression induced by tumor necrosis factor or interleukin-1. J Biol Chem 1992 Jan 25 1
22 1382834 Co-ordinate expression of c-fos, p53 and cytokeratin genes during the alteration of growth of human hepatoma cells. mRNA levels measured by reverse transcription and polymerase chain reaction. Cancer Lett 1992 Sep 30 2
23 1384667 Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism. Genes Chromosomes Cancer 1992 Jul 1
24 1391801 Alterations of the p53 gene in Philadelphia chromosome-positive leukemia including chronic myelogenous leukemia and acute leukemia. Int J Hematol 1992 Aug 1
25 1394133 p53 mutations in breast cancer. Cancer Res 1992 Oct 1 1
26 1394191 Sequence specificity of aflatoxin B1-induced mutations in a plasmid replicated in xeroderma pigmentosum and DNA repair proficient human cells. Cancer Res 1992 Oct 15 1
27 1396069 [Overexpression of p53 protein in human spontaneous esophageal carcinoma and fetal esophageal carcinoma induced by N-methyl-N-benzylnitrosamine (NMBzA)]. Zhonghua Zhong Liu Za Zhi 1992 Jul 4
28 1406679 Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53. Mol Cell Biol 1992 Nov 11
29 1406686 p53 is covalently linked to 5.8S rRNA. Mol Cell Biol 1992 Nov 12
30 1408139 p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus. Oncogene 1992 Oct 2
31 1413493 Abnormal p53 immunoreactivity and prognosis in node-negative breast carcinomas with long-term follow-up. Virchows Arch A Pathol Anat Histopathol 1992 2
32 1444195 Improved immunohistochemical detection of p53 protein in paraffin--embedded tissues reveals elevated levels in most head and neck and lung carcinomas: correlation with clinicopathological parameters. Anticancer Res 1992 Sep-Oct 3
33 1450522 Preference of human cdc2 kinase for peptide substrate. Pept Res 1992 Sep-Oct 5
34 1454521 Mutation of the casein kinase II phosphorylation site abolishes the anti-proliferative activity of p53. Nucleic Acids Res 1992 Nov 11 1
35 1459195 Effects of exogenous wild-type p53 on a human lung carcinoma cell line with endogenous wild-type p53. Exp Cell Res 1992 Dec 4
36 1466808 Conformational effects of selected cancer-related amino acid substitutions in the p53 protein. J Biomol Struct Dyn 1992 Oct 8
37 1468914 Overexpression of p53 in head and neck cancer. Head Neck 1992 Nov-Dec 1
38 1484319 p53 immunostaining in the distinction between benign and malignant mesothelial proliferations using formalin-fixed paraffin sections. J Pathol 1992 Dec 6
39 1486864 Relationship of H-ras-1, L-myc, and p53 polymorphisms with lung cancer risk and prognosis. Environ Health Perspect 1992 Nov 2
40 1501881 Biochemical properties of the growth suppressor/oncoprotein p53. Oncogene 1992 Sep 2
41 1506270 Growth inhibition by anchorage-deficiency is associated with increased level but reduced phosphorylation of mutant p53. Jpn J Cancer Res 1992 Apr 6
42 1510215 Mutant p53 protein is expressed in Bowen's disease. Am J Dermatopathol 1992 Jun 1
43 1519662 In situ hybridization and immunohistochemistry of p53 tumor suppressor gene in human esophageal carcinoma. Am J Pathol 1992 Sep 2
44 1520594 Prognostic significance of p53 overexpression in gastric and colorectal carcinoma. Br J Cancer 1992 Sep 1
45 1525830 Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 1992 Sep 18 1
46 1528930 Molecular alterations in human skin tumors. Prog Clin Biol Res 1992 1
47 1535157 Overlap of the p53-responsive element and cAMP-responsive element in the enhancer of human T-cell leukemia virus type I. Proc Natl Acad Sci U S A 1992 Jun 15 1
48 1540970 Overexpression and mutation of p53 in endometrial carcinoma. Cancer Res 1992 Mar 15 1
49 1545817 Human p53 and CDC2Hs genes combine to inhibit the proliferation of Saccharomyces cerevisiae. Mol Cell Biol 1992 Mar 1
50 1546693 Immunohistochemical study of p53 expression in microwave-fixed, paraffin-embedded sections of colorectal carcinoma and adenoma. Am J Clin Pathol 1992 Feb 3